Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Qin-yi Su"'
Autor:
Qin-Yi Su, Yan Zhang, Dan Qiao, Xia Song, Yang Shi, Rong-Qi Li, Ying-Fang Zhang, Sheng-Xiao Zhang
Publikováno v:
Exploration of Medicine, Vol 5, Iss 6, Pp 709-719 (2024)
Background: Rheumatoid arthritis (RA) is an autoimmune joint disease with systemic manifestations. Emerging evidence implicates the gut microbiota in the pathophysiology of RA. However, the specific changes in the gut microbiota in RA patients remain
Externí odkaz:
https://doaj.org/article/c65fe8d562004717bdd41a915072994f
Autor:
Qin-Yi Su, Jing Luo, Yan Zhang, Qian Li, Zhong-Qing Jiang, Zi-Rong Wen, Yu-Ying Wang, Mo-Ran Shi, Sheng-Xiao Zhang
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-9 (2024)
Abstract Background Difficult-to-treat Rheumatoid arthritis (D2T RA) is primarily characterised by failure of at least two different mechanism of action biologic/targeted synthetic disease-modifying antirheumatic drug (DMARDs) with evidence of active
Externí odkaz:
https://doaj.org/article/5ab7ddb6be99449abd2c368578eb91c6
Autor:
Qin-Yi Su, Yan Zhang, Dan Qiao, Xia Song, Yang Shi, Zhe Wang, Chen-Yan Wang, Sheng-Xiao Zhang
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
BackgroundAnkylosing spondylitis (AS) is a connective tissue disease that primarily affects spinal joints, peripheral joints, and paravertebral soft tissues, leading to joint stiffness and spinal deformity. Growing evidence has implicated gut microbi
Externí odkaz:
https://doaj.org/article/f30437f0b58b43f389568ab5d597174a
Autor:
Qin-Yi Su, Hao-Nan Zhou, Guo-Mei Xia, Rui-Yuan Zhang, Hong-Yuan Tian, Chang Su, Yu-Xin Liu, He-Yi Zhang, Ting Cheng, Yue-Hong Huo, Qian Li, Sheng-Xiao Zhang
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 2, Pp 227-237 (2024)
Abstract Introduction Currently, the cause of psoriatic arthritis (PsA) is unknown, and the effectiveness of current drug treatments is unsatisfactory. In March 2019, the US Food and Drug Administration (FDA) approved risankizumab, a humanized immuno
Externí odkaz:
https://doaj.org/article/02e8c4b1e856444593e5ab8c9f52f166
Autor:
Sheng-Xiao Zhang, Hao-Ran Chen, Jia Wang, Hong-Fang Shao, Ting Cheng, Ruo-Meng Pei, Qin-Yi Su, He-Yi Zhang, Xiao-Feng Li
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundImmunotherapy targeting factors related to immune imbalance has been widely employed for RA treatment. This study aimed to evaluate the efficacy and safety of low-dose interleukin (IL)-2 combined with tocilizumab (TCZ), a biologics targetin
Externí odkaz:
https://doaj.org/article/193bff2f11244cda91d0ec1adc9d4576
Publikováno v:
Basic and Clinical Andrology, Vol 33, Iss 1, Pp 1-9 (2023)
Abstract Background As one of the most critical proteins in the JAK/STAT signaling pathway, Janus kinase 2 (JAK2) is involved in many biological processes and diseases. Several observational studies have reported the role of JAK2 in erectile dysfunct
Externí odkaz:
https://doaj.org/article/600144084684460ba1cd4f59f2a8b5bc
Publikováno v:
Immunity, Inflammation and Disease, Vol 12, Iss 1, Pp n/a-n/a (2024)
Abstract Introduction Existing therapies of systemic lupus erythematosus (SLE) are efficacious only in certain patients. Developing new treatment methods is urgent. This meta‐analysis aimed to evaluate the efficacy and safety of low‐dose IL‐2 (
Externí odkaz:
https://doaj.org/article/472a7f51f1114a5c8739112fbfcfdc61
Autor:
Jia Wang, Sheng-Xiao Zhang, Jia-Song Chang, Ting Cheng, Xiao-Jing Jiang, Qin-Yi Su, Jia-Qi Zhang, Jing Luo, Xiao-Feng Li
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundRegulatory T cells (Tregs) have been found to play crucial roles in immune tolerance. However, the status of Tregs in refractory rheumatoid arthritis (RA) is still unclear. Moreover, low-dose interleukin-2 (IL-2) has been reported to select
Externí odkaz:
https://doaj.org/article/4070259569794e56b71872cca1adc081
Autor:
Qin-Yi Su, Sheng-Xiao Zhang, Liu Yang, Jing Luo, Xiao-Feng Li, Jia-Qi Zhang, Yan Zhang, Jun-Qi Liu, Lei Shi
Publikováno v:
Advances in Therapy. 40:102-116
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e1b4d39f432fa053a25ef99903beb54
https://doi.org/10.1007/s12325-022-02337-5
https://doi.org/10.1007/s12325-022-02337-5
Autor:
Qin-Yi, Su, Sheng-Xiao, Zhang, Liu, Yang, Jing, Luo, Xiao-Feng, Li, Jia-Qi, Zhang, Yan, Zhang, Jun-Qi, Liu, Lei, Shi
Publikováno v:
Advances in therapy.
Studies on the level of regulatory T (TAccording to published data from PubMed, Web of Science, Embase, Clinical Trials.gov, MEDLINE, Web of Knowledge, Cochrane Library, and FDA.gov, we determined the TThis meta-analysis included 12 studies. Compared
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3a0bbbda3084a83370aba6d0ec375de9
https://pubmed.ncbi.nlm.nih.gov/36287319
https://pubmed.ncbi.nlm.nih.gov/36287319